top of page

Aegis Capital Corp. acted as Sole Bookrunner on an $8.75 Million Underwritten Public Offering for Bluejay Diagnostics, Inc.

New York, New York / GLOBE NEWSWIRE/ June 28, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on an $8.75 Million Underwritten Public Offering for Bluejay Diagnostics, Inc. (NASDAQ: BJDX).

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

For more information, please visit:

About Aegis Capital Corporation 

Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research, sales and trading services to institutional and retail investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.

For more information about this offering or Investment Banking Services please email or call (212) 813-1010.

Brokerage and investment advisory services are offered through Aegis Capital Corporation, a member of FINRA and SIPC.  Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.

28 views0 comments


bottom of page